Fragmented sleep (SF) is a highly prevalent condition and a hallmark of sleep apnea, a condition that has been associated with increased cancer incidence and mortality. In this study, we examined the hypothesis that SF promotes tumor growth and progression through proinflammatory TLR4 signaling. In the design, we compared mice that were exposed to SF one week before engraftment of syngeneic TC1 or LL3 tumor cells and tumor analysis three weeks later. We also compared host contributions through the use of mice genetically deficient in TLR4 or its effector molecules MYD88 or TRIF. We found that SF enhanced tumor size and weight compared to control mice. Increased invasiveness was apparent in SF tumors, which penetrated the tumor capsule into surrounding tissues including adjacent muscle. Tumor-associated macrophages (TAM) were more numerous in SF tumors where they were distributed in a relatively closer proximity to the tumor capsule, compared to control mice. Although tumors were generally smaller in both MYD88-/-and TRIF-/-hosts, the more aggressive features produced by SF persisted. In contrast, these more aggressive features produced by SF were abolished completely in TLR4-/-mice. Our findings offer mechanistic insights into how sleep perturbations can accelerate tumor growth and invasiveness through TAM recruitment and TLR4 signaling pathways.
Introduction
In recent years, the possibility that sleep duration and overall sleep characteristics may affect overall cancer outcomes has been advanced (1). Indeed, in several epidemiologic studies spanning the last decade the presence of altered sleep duration, both shortened and prolonged sleep, has been associated with higher incidence or adverse prognosis for several solid tumors.
(2-17) However, although the role of the circadian clock system in tumorigenesis has been extensively explored (18, 19) , no animal models have thus far examined whether the association between disrupted sleep and tumorigenesis is indeed recapitulated, and if so, what potential mechanisms may underlie such associations.
In this context, some efforts to explore causal associations between a highly prevalent sleep disorder, namely obstructive sleep apnea (OSA), and cancer have also taken place (20, 21) , and have operated under the assumption that the intermittent hypoxemia that characterizes OSA patients during their sleep period is likely to mimic the biologic events that drive tumor growth(1, [22] [23] [24] [25] [26] [27] .The major findings from these initial studies indicate that the periodic oscillations in overall oxygenation during sleep in OSA patients impose overall adaptive changes in the tumor metabolic cellular substrate that enhances their proliferative and invasiveness properties (28) . However, these studies failed to explore another hallmark characteristic of OSA, namely sleep fragmentation (SF), i.e., the presence of recurrent arousals aimed at restoring airflow that lead to sleep discontinuity.
Using a similar logical paradigm, we hypothesized that chronic SF, a very frequent occurrence in many human disorders, including OSA, would be associated with altered solid tumor proliferation and invasiveness in a murine model (29, 30) . Furthermore, we posited that Male C57/B6, TLR4-/-, MYD88-/-and TRIF-/-mice weighing ~25 g, were purchased from Jackson Laboratories (Bar Harbor, Maine), housed in a 12 hr light/dark cycle (light on 7:00 am to 7:00 pm) at a constant temperature (24 ± 1°C) and allowed access to food and water ad libitum. The experimental protocols were approved by the Institutional Animal Use and Care
Materials and Methods

Animals:
Committee and are in close agreement with the National Institutes of Health Guide in the Care and Use of Animals. All efforts were made to minimize animal suffering and to reduce the number of animals used.
Sleep Fragmentation:
The custom-designed sleep fragmentation approach used to induce SF in rodents has been previously reported in detail (29, 33) , and relies on automated intermittent tactile stimulation of freely behaving mice in a standard laboratory mouse cage, using a nearsilent motorized mechanical sweeper. This method obviates the need for human contact and intervention, and does not involve introduction of foreign objects or touching of the animals during sleep. To induce sleep fragmentation, we chose a 2-min interval between each sweep, implemented during the light period (7:00 a.m. to 7:00 p.m.). Of note, 4-5 mice were housed in each cage to prevent isolation stress. Local Tumor Invasiveness: To assess differences in local tumor invasiveness between the SF and SC groups, 7 days after SF/SC initiation, C57/B6 mice were injected subcutaneously with TC1 cells into the lateral aspect of the right thigh using 1x10 5 cells in 0·2 ml PBS. 28 days after tumor cell inoculation, both SF and SC mice were euthanized and subjected to wide resection of the tumor tissue with its adjacent muscular and bone tissue of the thigh. The whole specimen was fixed in 4% PFA after it was cut into equivalent size pieces. Those specimens were embedded in paraffin and followed by cutting of 3-5 µm sections and were stained with H&E.
Tumor Cell Lines
Analysis of tumor infiltrating cells:
Tumors were mechanically disrupted in small pieces and maintained overnight in TC1 complete growth medium but without geneticin (G418). After 12 h, cells were harvested and filtered through a 100 µM nylon mesh cell strainer (352350, BD Falcon, Bedford, MA, USA). Prior to cell identification, viable cells were selected by using the aquafluorescent reactive dye (L34957, Invitrogen, Eugene, OR, USA). TAM were defined as CD45+, CD11b+, F4/80+ cells.
Isolation of TAM:
Tumors were mechanically disrupted and incubated in collagenase IV solution 1mg/mL for 1h at 37ºC. Cells were filtered through a 100 µM nylon mesh cell strainer and CD11b+ cells were isolated by magnetic labeling following manufacturer´s procedure Figure 4A ). TAM shift in polarity in SF tumors was also apparent based on increased transcriptional expression of M2 markers when compared to SC conditions, as evidenced by higher expression of Fizz1, Arg1 and Mrc1 (p<0.01; Figure 4B ). TAM from SFexposed mice also expressed higher levels of TLR4 compared to SC-exposed mice (P<0.02; Figure 4C ), but no changes in TLR2 or TLR6 were apparent (data not shown). Based on such findings, we examined TLR4 signaling as a potential pathway mediating SF-induced differences in tumorigenesis as described heretofore.
TLR4 signaling mediates SF-induced tumor progression: When compared to CS-C57/B6
mice, significant reductions in tumor size and weight occurred in SC-TLR4-/-mice (p<0.001; Figure 4D and 4E). More interestingly, the accelerated growth and increases in size induced by SF were completely abrogated in SF-TLR4-/-mice (Figure 4D and 4E; p<0.05 vs. SC-TLR4-/-mice). These effects were accompanied by significant reductions in TAM count in SF-TLR4-/-mice (p< 0.01; Figure 4F ).These results prompted further exploration as to whether TLR4 major downstream signaling pathways, namely MYD88 or TRIF were particularly and specifically recruited in SF. As shown in Figure 4G mice showed reductions in tumor weight compared to SF-C57/B6 (p< 0.03, p<0.01 respectively), but were still significantly larger than in SF-TLR4-/-mice. In addition, small, albeit statistically significant differences between SF and SC for MYD88 and TRIF null mice remained. 
Discussion
This study shows that chronically fragmented sleep, a highly prevalent condition associated with a multiplicity of human disorders, leads to accelerated tumor growth and invasiveness in mice and that such adverse effects are mediated, at least in part, by changes in TAM polarity and TLR4 signaling. Indeed, increases in M2 macrophage markers were apparent in tumors of SF-exposed mice, and were accompanied by increased in vivo and in vitro matrix metalloproteinase activity (34, 35).We further show that similar to previous reports, TLR4
signaling not only underlies significant components of tumor progression (34, 35), but also appears to mediate the differences in tumor proliferation between SF and SC conditions. Taken together, these findings provide initial, yet conclusive support for sleep-mediated modulation of tumorigenesis, and suggest that host-dependent immune mechanisms constitute a major pathway of such modulatory influences.
The paramount observation of the present study is the increased tumor proliferation and marked changes in invasiveness induced by chronic SF exposures mimicking several sleep disorders. As such, these observations provide initial observations in a murine model on the effects of perturbed sleep on cancer biology. Furthermore, our study offers potential biological plausibility to some of the findings derived from cross-sectional cohorts that have identified epidemiological associations between perturbed sleep or reduced sleep duration to the incidence and overall outcomes of cancer (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) . Thus, by establishing the biological plausibility of sleep as a modulator of the intrinsic properties of cancerous tumors, the rationale for further well- CAN-13-3014 indicated, the number of TAM was markedly increased in SF-exposed mice, and the differences were heterotopically distributed, with tumors from SF-exposed mice displaying preferential M2-type TAM localization in peripheral regions of the tumor. In contrast, SC-derived tumors had increased M1-type TAM, and these were located, in their greatest proportion within the core of the tumor. Therefore, we infer that the changes in macrophage polarity and location reflect some of M1 from the core to the tumor periphery during SF. Accordingly, genetic ablation of TLR4 in mice resulted in major curtailment of not only tumor growth, but also of the differences between SF and SC. However, the SF-SC differences in tumor size persisted in either MYD88-/-and TRIF-/-mice, suggesting that either both TLR4 signaling pathways are required for SF-induced effect on tumor growth, or that the differences between SF and SC are not distinguishable once tumor growth is so markedly reduced by TLR4 genetic ablation. As with all other observations reported herein, transfer of the findings from an in vivo murine model to an in vitro model is obviously impossible, thereby hampering our ability to study mechanisms of SF effects in greater detail. We should also point out that the mechanisms underlying SF-induced activation of TLR4 signaling in macrophages, and the changes in TAM polarity are completely unknown, and this specific area will have to be explored in the future.
In summary, the present study conclusively demonstrates that perturbed sleep leads to major changes in tumorigenesis, characterized by increased tumor cell proliferation and invasion.
Alterations in TAM phenotypes, particularly in the tumor periphery, and in TLR4 expression in TAM further suggest that SF-induced effects on tumor growth and invasion may be mediated by host-related responses, particularly those involving innate immunity, and that improved understanding of such pathways may permit improved therapeutic interventions. Considering the high prevalence of sleep disorders and cancer in middle age or older populations, there are far reaching implications to current findings regarding potential adverse outcomes in patients in whom the 2 conditions co-exist. 
